Skip to content

Cryolipolysis On Cardiovascular Risk Factors In Obese Hypertensive Post Menopausal Women

Effect Of Cryolipolysis On Cardiovascular Risk Factors In Obese Hypertensive Post Menopausal Women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202305888250839
Enrollment
40
Registered
2023-05-30
Start date
2022-12-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Musculoskeletal Diseases Nutritional, Metabolic, Endocrine post menopause

Interventions

diet and aerobic exercises
cryolipolys and diet and aerobic exercises

Sponsors

faculty of physical therapy cairo university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The women will be selected according to the following criteria: • The age will range from 50 to 60 years. • They will experience menopause at least 3 years. • The women in the study will be diagnosed as having hypertension. • Their blood pressure must be range from 140/90 to 180/110 mmHg. • They must receive antihypertensive drug (Concor 5 mg). • Body mass index (BMI) will range from 30 to 34.9 kg/m2. • All women will have abdominal obesity; their abdominal circumference will be >90cm. • Waist hip ratio will be >0.85.

Exclusion criteria

Exclusion criteria: Patients will be excluding from this study for any of the following cases: • Smokers, athletic women. • Anemia, diabetes, any cardiorespiratory diseases, malignancy. • Eczema or dermatitis, skin disease, scar, hernia in the treatment area. • Suspicious cutaneous lesions, history of keloids or hypertrophic scarring, infection, pain or abscess in the treatment area, presence of tattoos or body piercing in the treatment area, autoimmune disorders. • Presence of pacemaker or metallic implants in the treatment area. • Receiving anti-depressant, any hormonal replacement therapy, or any medication to reduce their body weight. • Previous operation in the abdominal region.

Design outcomes

Primary

MeasureTime frame
lipid profile;Body Mass Index

Secondary

MeasureTime frame
blood pressure ;Skin Fold;Waist - Hip Ratio

Countries

Egypt

Contacts

Public ContactAbeer Eldeeb

Professor

beroeldeeb@yahoo.com01001811588

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026